MedTrace Logo

Growth Hormone's Effect on Endothelial Progenitor Cells

NCT00397592 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2007-07-03

No results posted yet for this study

Summary

To assess the effect of short-term low-dose growth hormone therapy on the mobilization of endothelial progenitor cells from the bone marrow within a group of healthy adults.

Conditions

Interventions

DRUG

Growth Hormone

Sponsors & Collaborators

  • National Center for Research Resources (NCRR)

    collaborator NIH

  • Vanderbilt University

    lead OTHER

Principal Investigators

  • Doug Vaughan, MD · Vanderbilt University Medical Center

Study Design

Allocation
NON_RANDOMIZED
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-08-31
Completion
2007-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00397592 on ClinicalTrials.gov